Pirarubicin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pirarubicin, covering 2016-09-16 to 2020-05-19. Get the full timeline:
Most recent: Clinical Trial Update: Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma [Phase 2, Phase 3]